1 – 10 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency: the importance of early identification
(
- Contribution to journal › Article
-
Mark
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening
(
- Contribution to journal › Article
- 2021
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
(
- Contribution to journal › Article
- 2020
-
Mark
Decreased risk of ischemic heart disease in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison with the general population
(
- Contribution to journal › Article
-
Mark
Kardiellt troponin – en biomarkör för hjärt–kärlsjukdom vid KOL
(
- Contribution to journal › Article
- 2019
-
Mark
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Liver disease in adults with severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
(
- Contribution to journal › Article